Peter Mclaughlin

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program

Journal of Clinical Oncology · 1998 · First of 16 authors · Corresponding · 2,302 citations

Follicular lymphoma international prognostic index

Blood · 2004 · 1,415 citations